Weiss Ratings reaffirmed their sell (e) rating on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a report published on Friday,Weiss Ratings reports.
Separately, StockNews.com cut 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.
Get Our Latest Research Report on XXII
22nd Century Group Stock Up 0.5 %
Hedge Funds Weigh In On 22nd Century Group
An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP purchased a new stake in 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent SEC filing. Institutional investors own 18.06% of the company’s stock.
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Articles
- Five stocks we like better than 22nd Century Group
- Most Volatile Stocks, What Investors Need to Know
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What Are Dividend Challengers?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.